Another shot we offer at LIVation is a GLP-1 agonist, but it is also a GIP agonist, meaning it works on both your GLP-1 receptor and gastric inhibitory polypeptide receptor
doi: 10.1038/S41433-024-03101-5 83 JungBJLeeMYJeonS
Common concerns regarding safety, legality, and side effects are addressed, and the article closes by highlighting the growing trend toward biohacking weight loss, metabolic reset programs, and personalized peptide-based therapies
Millions of members who had relied on medications like Wegovy, Zepbound, and Saxenda woke up to letters explaining that their weight loss medications would no longer be covered as of January 1, 2026
Slower Titration Option Some practitioners use a more gradual escalation with 2 mg increments every four weeks
Ascletis reported enhanced fat loss with ASC47 in semaglutide combo studies